Strengths and weaknesses of pneumococcal conjugate vaccines.

Micoli, Francesca; Romano, Maria Rosaria; Carboni, Filippo; Adamo, Roberto; Berti, Francesco

Micoli, Francesca; Romano, Maria Rosaria; Carboni, Filippo; Adamo, Roberto; Berti, Francesco.

Affiliation

Micoli F; GSK Vaccines Institute for Global Health, Siena, Italy. francesca.x.micoli@gsk.com.
Romano MR; GSK Vaccines, Siena, Italy.
Carboni F; GSK Vaccines, Siena, Italy.
Adamo R; GSK Vaccines, Siena, Italy.
Berti F; GSK Vaccines, Siena, Italy.

Glycoconj J ; 40(2): 135-148, 2023 04.

Article in En | MEDLINE | ID: mdl-36652051

Subject(s)

Pneumococcal Infections; Pneumococcal Vaccines; Humans; Pneumococcal Vaccines/therapeutic use; Streptococcus pneumoniae; Pneumococcal Infections/prevention & control; Pneumococcal Infections/epidemiology; Vaccination; Vaccines, Conjugate/therapeutic use; Antibodies, Bacterial

Key words

Bacterial infection; Conjugate; Polysaccharide; Streptococcus pneumoniae; Vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections / Pneumococcal Vaccines Limits: Humans Language: En Journal: Glycoconj J Journal subject: BIOQUIMICA / METABOLISMO Year: 2023 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google